Dr. Eshaghian has a long tradition of participation in national and international clinical research trials. His research has been presented at national and international conferences and subsequently published in the world’s premier medical journals. Our research department includes experienced personnel who attend to the countless details that are required to produce pure scientific data. Our cardiologists remain fully active as principal investigators or sub-investigators in all ongoing trials. Our participation in clinical trials offers our patients an opportunity to enroll in studies that offer promising new therapeutic options.

Current Research trials:

PEGASUS- TIMI 54: AstraZeneca.
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction
http://clinicaltrials.gov/ct2/show/NCT01225562

REVEAL-HPS-3 TIMI 55; Merck

Randomized Evaluation of the Effects of Anacetrapid through Lipid-  Modification): A large-scale, randomized placebo-controlled trial of the clinical effects of anacetrapid among people with established vascular disease.